lobbying_activities: 2815656
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2815656 | 2e005744-91c0-4421-842e-a8b2851d337e | Q2 | CHAMBER HILL STRATEGIES | 400645947 | BIOMARIN PHARMACEUTICAL INC. | 2022 | second_quarter | TAX | Issues generally related to the Orphan Drug Tax Credit, including provisions in H,R. 2623, Camerons Law and H.R. 5376, Build Back Better Act. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2022-07-08T12:37:01-04:00 |